Molecular Subtyping and Precision Medicine for Pancreatic Cancer

Substantial progress in recent years has dramatically increased our knowledge of the molecular basis of cancer, revealing new potential therapeutic targets and paving the way for effective personalised medicine for the treatment of many tumour types. However, pancreatic cancer has been lagging behin...

Descripción completa

Detalles Bibliográficos
Autores principales: Froeling, Fieke E. M., Casolino, Raffaella, Pea, Antonio, Biankin, Andrew V., Chang, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794969/
https://www.ncbi.nlm.nih.gov/pubmed/33406790
http://dx.doi.org/10.3390/jcm10010149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794969/
https://www.ncbi.nlm.nih.gov/pubmed/33406790
http://dx.doi.org/10.3390/jcm10010149

Ejemplares similares